Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InfuSystem Holdings ( (INFU) ) has issued an update.
InfuSystem Holdings, Inc., a national health care service provider focused on outpatient support for durable medical equipment manufacturers and health care providers, operates two main platforms: Patient Services and Device Solutions. Patient Services offers clinic-to-home solutions in oncology, pain management and wound therapy, while Device Solutions covers direct payer rentals, equipment sales and biomedical services, all supported by field-based teams and Centers of Excellence in several U.S. states and Ontario, Canada.
On April 30, 2026, InfuSystem announced it would release its first quarter 2026 financial results on May 7, 2026, before the market opens, and would host an investor conference call that same day at 9:00 a.m. Eastern Time to discuss the figures. The scheduled results release and call underscore the company’s ongoing communication with investors and other stakeholders regarding its financial performance and operational progress in the outpatient healthcare services market.
The most recent analyst rating on (INFU) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.
Spark’s Take on INFU Stock
According to Spark, TipRanks’ AI Analyst, INFU is a Outperform.
Score driven primarily by improving financials (strong recent profitability and free cash flow plus significant de-leveraging) and a supportive earnings outlook with margin/cash-flow catalysts from cost savings. Technicals are constructive but show elevated momentum, while valuation (P/E ~28 and no dividend) limits upside in the score.
To see Spark’s full report on INFU stock, click here.
More about InfuSystem Holdings
InfuSystem Holdings, Inc., listed on the NYSE American as INFU, is a national health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. The company operates through two platforms: Patient Services, which focuses on clinic-to-home care in oncology, pain management and wound therapy, and Device Solutions, which provides direct payer rentals, pump and consumable sales, and biomedical services and repair.
Headquartered in Rochester Hills, Michigan, InfuSystem delivers local, field-based customer support and runs Centers of Excellence across Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada, strengthening its geographic reach. Its Device Solutions platform supports and complements Patient Services while leveraging its service orientation to win incremental business from direct payer clients, positioning the company as a key player in outpatient durable medical equipment services.
Average Trading Volume: 119,155
Technical Sentiment Signal: Buy
Current Market Cap: $198.7M
For a thorough assessment of INFU stock, go to TipRanks’ Stock Analysis page.